Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03GOP
|
|||
| Former ID |
DNCL003228
|
|||
| Drug Name |
Imvamune smallpox vaccine
|
|||
| Synonyms |
Imvamune (TN)
Click to Show/Hide
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Approved | [1] | |
| Monkeypox virus infection [ICD-11: 1E71] | Phase 3 | [2] | ||
| Smallpox [ICD-11: 1E70; ICD-10: B03] | Phase 3 | [3] | ||
| Company |
BM ImmunoTherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Bavarian Nordic. | |||
| REF 2 | ClinicalTrials.gov (NCT02977715) IMVAMUNE Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.